EN es PT

About GBT
Therapeutic Areas
R&D
Compliance
Countries
- Argentina
- Bolivia
- Brazil
- Chile
- Colombia
- Ecuador
- Mexico
- Paraguay
- Peru
- Uruguay
Newsroom

Home
/
País - Colômbia
/
Inmunology
/
Inflammation and Specialty Treatment
/
BERIATE 500 UI

BERIATE 500 UI

Media Requests

If you are a member of the press, please send a question to our Corporate Affairs team here.

Click here

Press Release

To access all the announcements published by GBT Click here

Tweets by GbtBiotoscana

X

Contact

WTC Free Zone, Dr Luis Bonavita 1294, #2004
Montevideo, 11300, Uruguay
+598 2626 2344
info@grupobiotoscana.com

About GBT
Therapeutic Areas
R&D
Compliance
Countries
- Argentina
- Bolivia
- Brazil
- Chile
- Colombia
- Ecuador
- Mexico
- Paraguay
- Peru
- Uruguay
Newsroom

© 2022 Grupo Biotoscana. All rigths reserved
LinkedIn